BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38203597)

  • 21. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
    Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
    APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection.
    Masouris I; Klein M; Ködel U
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):875-885. PubMed ID: 32479125
    [No Abstract]   [Full Text] [Related]  

  • 23. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
    Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
    J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study.
    Ørbæk M; Gynthersen RMM; Mens H; Brandt C; Stenør C; Wiese L; Andersen ÅB; Møller HJ; Lebech AM
    Clin Chim Acta; 2023 Mar; 543():117299. PubMed ID: 36931585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic relevance of the chemokine CXCL13 and anti-C6 peptide antibodies in patients with neuroborreliosis].
    Pícha D; Moravcová L; Smíšková D
    Epidemiol Mikrobiol Imunol; 2017; 66(2):80-85. PubMed ID: 28691831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
    Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
    Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
    Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
    AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
    van Gorkom T; van Arkel GHJ; Heron M; Voet W; Thijsen SFT; Kremer K
    J Clin Microbiol; 2021 Aug; 59(9):e0025521. PubMed ID: 34132584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
    Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
    Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
    Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
    van Burgel ND; Bakels F; Kroes AC; van Dam AP
    J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
    Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
    BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.
    Pilz G; Wipfler P; Otto F; Hitzl W; Afazel S; Haschke-Becher E; Trinka E; Harrer A
    J Neuroinflammation; 2019 Jan; 16(1):13. PubMed ID: 30660201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
    Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
    [No Abstract]   [Full Text] [Related]  

  • 35. CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis - A prospective multicentre study in Austria.
    Waiß C; Ströbele B; Graichen U; Klee S; Gartlehner J; Sonntagbauer E; Hirschbichler S; Tinchon A; Kacar E; Wuchty B; Novotna B; Kühn Z; Sellner J; Struhal W; Bancher C; Schnider P; Asenbaum-Nan S; Oberndorfer S
    J Cent Nerv Syst Dis; 2024; 16():11795735241247026. PubMed ID: 38706882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
    Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
    Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.
    Pöyhönen H; Lähdesmäki T; Hytönen J; Peltola V
    Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
    Ziegler K; Rath A; Schoerner C; Meyer R; Bertsch T; Erbguth F; Bogdan C; Steinmann J; Held J
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
    Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
    JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.